Home›Screener›XNCR›Profile
D
38/100

Xencor Inc

XNCRBispecific Antibodies
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

Xencor Inc (XNCR) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 4 Phase 1[2].

No Form 4 insider filings for XNCR were recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. SEC EDGAR · 0001326732 (2026-04-11) ↗
🔬
Clinical Trials
5
NCT05032040Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer, Cervical Carcinoma, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05433142Clear Cell Renal Cell Carcinoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06276491Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06619990Ulcerative Colitis (UC)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07230353Rheumatoid Arthritis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
0 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Sector Peers (Bispecific Antibodies)
MRUSMerus NV
C
ZYMEZymeworks Inc
D
Data Provenance
cik1 verified
clinical trial5 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR